Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

09/03/3513

Blasticidin S.HCl

09/03/3513
90357-06-5

Bicalutamide

90357-06-5
34911-55-2

Bupropion

34911-55-2
18010-40-7

Bupivacaine HCl

18010-40-7
102280-35-3

Baquiloprim

102280-35-3
9041-93-4

Bleomycin Sulfate (mixture A2/B2)

9041-93-4
1405-89-6

Bacitracin zinc

1405-89-6
63659-19-8

Betaxolol HCl

63659-19-8
97-18-7

Bithionol

97-18-7
58-85-5

Biotin

58-85-5
482-25-7

Biacangelicin

482-25-7
33386-08-2

Buspirone HCl

33386-08-2
08/09/5534

Beclometasone Dipropionate

08/09/5534
55-21-0

Benzamide

55-21-0
622-78-6

Benzyl Isothiocyanate

622-78-6
17316-67-5

Butafosfan

17316-67-5
71048-99-2

Bialaphos sodium salt

71048-99-2
5593-20-4

Betamethasone dipropionate

5593-20-4
378-44-9

Betamethasone

378-44-9
5579-84-0

Betahistine 2HCl

5579-84-0